PUMA BIOTECHNOLOGY, INC. Cash and Cash Equivalents
PUMA BIOTECHNOLOGY, INC. (PBYI) had Cash and Cash Equivalents of $36.54 million as of 2026-06-30, per its 10-Q filed 2026-08-06.
Financial Statements › Balance Sheet › Assets › Assets, Current › Cash, Cash Equivalents, and Short-Term Investments
us-gaap:CashAndCashEquivalentsAtCarryingValue · last filed 2026-08-06
- 2026-06-30: Cash and Cash Equivalents, at Carrying Value $36.54M.
- 2026-03-31: Cash and Cash Equivalents, at Carrying Value $36.19M.
- 2025-12-31: Cash and Cash Equivalents, at Carrying Value $29.64M.
- 2025-09-30: Cash and Cash Equivalents, at Carrying Value $53.52M.
| Period end | Cash and Cash Equivalents, at Carrying Value | Cash and Cash Equivalents, at Carrying Value as first filed |
|---|---|---|
| 2026-06-30 | $36.54M 10-Q · filed 2026-08-06 | |
| 2026-03-31 | $36.19M 10-Q · filed 2026-05-07 | |
| 2025-12-31 | $29.64M 10-Q · filed 2026-08-06 | |
| 2025-09-30 | $53.52M 10-Q · filed 2025-11-06 | |
| 2025-06-30 | $54.66M 10-Q · filed 2025-08-07 | |
| 2025-03-31 | $63.03M 10-Q · filed 2025-05-08 | |
| 2024-12-31 | $69.22M 10-K · filed 2026-02-26 | |
| 2024-09-30 | $67.26M 10-Q · filed 2024-11-07 | |
| 2024-06-30 | $67.15M 10-Q · filed 2024-08-01 | |
| 2024-03-31 | $76.75M 10-Q · filed 2024-05-02 | |
| 2023-12-31 | $84.58M 10-K · filed 2025-02-27 | |
| 2023-09-30 | $81.80M 10-Q · filed 2023-11-02 | |
| 2023-06-30 | $60.01M 10-Q · filed 2023-08-03 | |
| 2023-03-31 | $61.39M 10-Q · filed 2023-05-04 | |
| 2022-12-31 | $76.20M 10-K · filed 2024-02-29 | |
| 2022-09-30 | $77.96M 10-Q · filed 2022-11-03 | |
| 2022-06-30 | $52.76M 10-Q · filed 2022-08-04 | |
| 2022-03-31 | $63.91M 10-Q · filed 2022-05-05 | |
| 2021-12-31 | $63.13M 10-K · filed 2023-03-02 | |
| 2021-09-30 | $63.95M 10-Q · filed 2021-11-04 | |
| 2021-06-30 | $89.85M 10-Q · filed 2021-08-05 | |
| 2021-03-31 | $95.65M 10-Q · filed 2021-05-06 | |
| 2020-12-31 | $85.29M 10-K · filed 2022-03-03 | |
| 2020-09-30 | $90.08M 10-Q · filed 2020-11-05 | |
| 2020-06-30 | $90.90M 10-Q · filed 2020-08-06 | |
| 2020-03-31 | $83.39M 10-Q · filed 2020-05-07 | |
| 2019-12-31 | $60.04M 10-K · filed 2021-03-01 | |
| 2019-09-30 | $58.90M 10-Q · filed 2019-11-07 | |
| 2019-06-30 | $27.16M 10-Q · filed 2019-08-09 | |
| 2019-03-31 | $48.79M 10-Q · filed 2019-05-10 | |
| 2018-12-31 | $108.42M 10-K · filed 2020-02-28 | |
| 2018-09-30 | $68.30M 10-Q · filed 2018-11-05 | |
| 2018-06-30 | $95.91M 10-Q · filed 2018-08-09 | |
| 2018-03-31 | $78.55M 10-Q · filed 2018-05-10 | |
| 2017-12-31 | $81.70M 10-K · filed 2019-03-01 | |
| 2017-09-30 | $79.72M 10-Q · filed 2017-11-09 | |
| 2017-06-30 | $80.82M 10-Q · filed 2017-08-09 | |
| 2017-03-31 | $105.09M 10-Q · filed 2017-05-10 | |
| 2016-12-31 | $194.49M 10-K · filed 2018-03-09 | |
| 2016-09-30 | $52.54M 10-Q · filed 2017-11-09 | |
| 2016-06-30 | $57.84M 10-Q · filed 2017-08-09 | |
| 2016-03-31 | $78.22M 10-Q · filed 2017-05-10 | |
| 2015-12-31 | $31.57M 10-K · filed 2018-03-09 | |
| 2015-09-30 | $23.60M 10-Q · filed 2016-11-09 | |
| 2015-06-30 | $59.84M 10-Q · filed 2016-08-09 | |
| 2015-03-31 | $155.47M 10-Q · filed 2016-05-10 | |
| 2014-12-31 | $38.54M 10-K · filed 2018-03-09 | |
| 2014-09-30 | $28.26M 10-Q · filed 2015-11-09 | |
| 2014-06-30 | $55.36M 10-Q · filed 2015-08-10 | |
| 2014-03-31 | $163.38M 10-Q · filed 2015-05-11 | |
| 2013-12-31 | $43.04M 10-K · filed 2017-03-01 | |
| 2013-09-30 | $51.26M 10-Q · filed 2014-11-10 | |
| 2013-06-30 | $60.90M 10-Q · filed 2014-08-11 | |
| 2013-03-31 | $91.65M 10-Q · filed 2014-05-12 | |
| 2012-12-31 | $137.41M 10-K · filed 2016-02-29 | |
| 2012-09-30 | $33.35M 10-Q · filed 2013-11-12 | $33.35M 10-Q · filed 2012-11-14 |
| 2012-06-30 | $41.00M 10-Q · filed 2013-08-06 | $41.00M 10-Q · filed 2012-08-14 |
| 2012-03-31 | $50.17M 10-Q · filed 2013-05-09 | $50.17M 10-Q · filed 2012-05-15 |
| 2011-12-31 | $53.38M 10-K · filed 2015-03-02 | $53.38M 10-K · filed 2012-03-29 |
| 2011-09-30 | $25.47K 10-Q · filed 2012-11-14 | |
| 2011-06-30 | $1.75K 10-Q · filed 2011-08-15 | |
| 2011-03-31 | $0.00 10-Q · filed 2012-05-15 | |
| 2010-12-31 | $0.00 10-K · filed 2013-04-01 | $462.00 10-Q · filed 2011-08-15 |
| 2010-09-15 | $0.00 10-K · filed 2013-04-01 | |
| 2010-06-30 | $1.80K 10-Q · filed 2011-08-15 | |
| 2009-12-31 | $2.41K 10-Q · filed 2011-08-15 | |
| 2007-04-26 | $0.00 10-Q · filed 2011-08-15 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| ARVINAS, INC. (ARVN) | United States | $0.510B | 58.38 |
| CAPRICOR THERAPEUTICS, INC. (CAPR) | United States | $0.499B | -10.81 |
| Evolus, Inc. (EOLS) | United States | $0.519B | -13.32 |
| Ovid Therapeutics Inc. (OVID) | United States | $0.487B | -14.41 |
| CRESCENT BIOPHARMA, INC. (CBIO) | United States | $0.529B | -5.20 |
| ASSEMBLY BIOSCIENCES, INC. (ASMB) | United States | $0.481B | -13,053.96 |
| Indaptus Therapeutics, Inc. (INDP) | United States | $0.537B | |
| MapLight Therapeutics, Inc. (MPLT) | United States | $0.459B | -7.10 |
| Quoin Pharmaceuticals Ltd. (QNRX) | $0.443B | -17.85 | |
| Phathom Pharmaceuticals, Inc. (PHAT) | United States | $0.572B | -8.76 |